ICU Medical, Inc. (Nasdaq:ICUI) announced it is launching the Neutron™ needlefree catheter patency device with constant neutral pressure at the Association for Vascular Access Annual Scientific Meeting in San Jose, CA. Neutron is the world's first and only device with FDA 510k clearance to claim the ability to prevent fluid displacement during an IV bag run-dry, infusion pump stop, or patient vascular pressure changes caused by coughing, sneezing or movement - all of which have been associated with loss of catheter patency.

ICU Medical, Inc. engages in the development, manufacture, and sale of medical technologies used in vascular therapy, oncology, and critical care applications.

Read the full article and the disclaimer at: http://drstockpick.com/?p=22373